Characteristics, Risk Factors, and Adverse Outcomes of Hyperkalemia in Acute-on-Chronic Liver Failure Patients

Jun-Jun Cai1, Kai Wang2,3, Hui-Qing Jiang1

  • 1Department of Gastroenterology, The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Gastroenterology, Hebei Institute of Gastroenterology, Shijiazhuang, China.

Insights

Hyperkalemia significantly increases 90-day mortality in patients with acute-on-chronic liver failure (ACLF). This complication is strongly linked to acute kidney injury (AKI), with combined AKI and hyperkalemia leading to the worst outcomes.

Area of Science:

  • Hepatology
  • Nephrology
  • Critical Care Medicine

Background:

  • Hyperkalemia is a known complication in cirrhosis, but its specific role in acute-on-chronic liver failure (ACLF) remains understudied.
  • Understanding hyperkalemia's risk factors and impact on ACLF patient outcomes is crucial for improving clinical management.

Purpose of the Study:

  • To investigate the clinical characteristics and risk factors of hyperkalemia in ACLF patients.
  • To determine the impact of hyperkalemia on 90-day mortality in ACLF patients, particularly in the context of acute kidney injury (AKI).

Main Methods:

  • Retrospective analysis of 650 ACLF patients.
  • Multivariable regression models were used to identify risk factors for hyperkalemia and its association with 90-day mortality.

Main Results:

  • 12.2% of ACLF patients developed hyperkalemia during hospitalization.
  • Acute kidney injury (AKI) and higher admission serum potassium were independent risk factors for hyperkalemia.
  • Hyperkalemia independently predicted 90-day mortality in both AKI and non-AKI ACLF patients, with significantly higher mortality rates observed in hyperkalemic patients.
  • Hepatic encephalopathy, gastrointestinal bleeding, AKI, hyperkalemia, elevated TBIL and INR, and higher MELD and CLIF-SOFA scores were independent predictors of 90-day mortality.

Conclusions:

  • Hyperkalemia is an independent predictor of increased 90-day mortality in ACLF patients.
  • Hyperkalemia is significantly associated with AKI in ACLF.
  • The combination of AKI and hyperkalemia confers the poorest prognosis in ACLF patients.
Abstract

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.3K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
940
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
488
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
852
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
536